Items where authors include "Danson, S"

Article

Lee, RW, Danson, S, Elliot, M et al. (8 more authors) (2022) Importance of clinical research for the UK's 10-year cancer plan. The Lancet Oncology. ISSN 1470-2045

Coen, O, Corrie, P, Marshall, H et al. (17 more authors) (2021) The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma. BMC Cancer, 21. 761. ISSN 1471-2407

Kennedy, F orcid.org/0000-0002-4910-2505, Shearsmith, L orcid.org/0000-0002-6575-0529, Ayres, M et al. (5 more authors) (2021) Online monitoring of patient self-reported adverse events in Early Phase Clinical Trials: views from patients, clinicians, and trial staff. Clinical Trials, 18 (2). pp. 168-179. ISSN 1740-7745

Danson, S, Mulvey, MR orcid.org/0000-0002-6357-3848, Turner, L et al. (6 more authors) (2019) An exploratory randomized-controlled trial of the efficacy of the Src-kinase inhibitor saracatinib as a novel analgesic for cancer-induced bone pain. Journal of Bone Oncology, 19. 100261. ISSN 2212-1374

Danson, S, Hook, J, Marshall, H orcid.org/0000-0003-0944-0152 et al. (4 more authors) (2019) Are we over-treating with checkpoint inhibitors? British Journal of Cancer, 121 (8). pp. 629-630. ISSN 0007-0920

Abbosh, C, Birkbak, NJ, Wilson, GA et al. (425 more authors) (2017) Phylogenetic ctDNA analysis depicts early stage lung cancer evolution. Nature, 545. pp. 446-451. ISSN 0028-0836

Proceedings Paper

Velikova, G orcid.org/0000-0003-1899-5942, Shearsmith, L, Kennedy, F et al. (4 more authors) (2019) Patient, clinicians and trial staff views on the collection of patient-reported adverse events in Early Phase Clinical Trials. In: Quality of Life Research. 26th Annual Conference of the International Society for Quality of Life Research, 20-23 Oct 2019, San Diego, CA, USA. Springer Verlag , S99-S100.